Mednet Logo
CommunityHospital Medicine

How do you talk to patients about clinical trials?

5 Answers
Mednet Member
Mednet Member
Medical Oncology · Kaiser Permanente, Northern California
Answered on

I try to incorporate the clinical trial idea into the standard of care recommendation/discussion at the time of initial treatment decision making. After making a standard of care rx recommendation, I tell patients that my recommendation is based upon this treatment being the winner of a prior trial ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Rutgers Cancer Institute of New Jersey
Answered on

I tend to express clinical trials as a normal part of discussion. Using the same skills as in discussing hospice, I utilize the ASK-TELL-ASK or SPIKES model.

During my interview, I ask (Ask of ASK-TELL-ASK or P of SPIKES) patients what they know about their cancer, their treatment options, their co...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Rush University Medical Center
Answered on

Some additional thoughts relevant to clinical trials in the multi-modality, curative intent, initial management setting:

1. It is unbelievably helpful if the patient and family hear the same message about best standard option, best clinical trial option, and why the clinical trial seems like the bet...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University Hospitals
Answered on

I discuss clinical trials as a potential treatment option after discussing a standard of care option. For some patients, standard of care isn’t an option. Usually in the first line setting, a trial drug (or placebo) is given in conjunction with standard of care, so the main downside is increased tox...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Texas Oncology-San Antonio Babcock
Answered on

For patients in the metastatic settings where standard of care is approved and we have ample data of its efficacy and potential toxicity, I would definitely be in favor of delivering SOC first, and I will mention then that when/if this first line therapy fails, we have many other potential drugs in ...

Join for free or sign in to see the full answer